The window that matters is narrow. Today is April 17, 2026. Genpact historically reports Q1 in the first week of May (Q1'25 dropped May 1); the Q1'26 call is the first test of whether management re-opens the bookings conversation after quietly dropping a $200M YoY decline into the 10-K footnotes. The stock has round-tripped from $50 (April 2025) to a fresh 52-week low of $34.18 on April 10, 2026 — a 32% drawdown into the print. What the market is actually asking is narrow: is ATS still compounding at 17%+, or has the AI pivot already decelerated before it crossed 30% of revenue?
No Results
**The single number that moves the stock on May 1.** Advanced Technology Solutions grew 17% in FY25 and is the only reason this is not a 9x P/E story. A Q1 ATS growth print below 15% collapses the re-rating thesis; a print at or above 17% with flat-to-up bookings clears the path back to $45. Everything else on the call is secondary.
No Results
Sell-side estimates for FY26 sit at $5.43B revenue (6.8% growth) and $3.59 EPS (14.7% growth) — a modest step-up from FY25's 6.6% / 11% actuals. At $36.65, the stock is priced as if ATS decelerates to low-teens and margins stall, which is a low bar that management has cleared every quarter under Kalra. The catalyst isn't exotic; it's a clean Q1 print with bookings back on the headline and ATS at 17%+.
**The peer-valuation gap is unusually wide for a company growing this well.** Quant flagged it directly: G grows 6.6% at 1.44x EV/Sales while EXLS grows 3.5% at 2.43x and WNS grows 2.3% at 2.92x. That is a 41% discount to a slower-growing direct peer. Closing even half the gap on a clean ATS print implies mid-$50s — well above the April 2025 high of $50.
**Cash generation is real and under-appreciated.** FY25 FCF of $725M (+36% YoY, 11.6% yield, 14.3% margin) at a $6.2B market cap is a datapoint the tape is ignoring. SBC is only 1.8% of revenue — SBC-adjusted FCF yield is still 10.2%. Combined with 0.86x net debt/EBITDA and ~$215M/yr returned via buybacks and dividends, downside is cushioned even if the AI thesis stalls.
**Governance is quietly A-grade for this vintage of IT services.** Sherlock: 11-of-12 independent board, independent Chair separate from CEO (Madden, 20-yr tenure), 92% say-on-pay, anti-hedging/pledging enforced, clawback active. The tell-tale signal is Nalanda India Equity Fund (Pulak Prasad) holding 7.74% since 2021 and not trimming — quality-compounder funds do not sit patient at 7%+ for five years on a melting ice cube.
**Guidance credibility has been rebuilt under Kalra.** Historian: 8/10 — above-guide prints in 6 of 8 quarters, two dividend raises, and the one real stumble (Q1'25 tariff guide-down) was reversed within six months with the full year landing at 6.6%. When this management team says FY26 will grow 7%+, the base rate for hitting it is high.
**The setup into Q1 is asymmetric on sentiment.** Stock is 32% below the April 2025 high, sits at 10.2x forward, and has had every narrative cut priced in — tariff, bookings, AI displacement, margin stall. A clean ATS print at 17%+ with bookings disclosed on the headline is the kind of thing that gaps stocks through $40 because the bar is low, not because the news is extraordinary.
**Warren's "productivity giveback" math is the thesis-breaker nobody wants to talk about.** The 2025 investor day disclosed that accounts rotated to agentic delivery grew only 3% net of productivity concessions clients capture on renewal. If that is the steady-state rate for the 76% Core Business Services book as AI permeates it, the group grows 4–5% no matter how fast ATS runs — and the multi-year re-rating story is structurally capped.
**Bookings fell $200M YoY and management stopped talking about them.** Historian flagged this as the canonical "quietly dropped metric" pattern: $5.7B in FY24 was a press-release headline; $5.5B in FY25 appeared only in the 10-K MD&A. Bookings lead revenue by 3–4 quarters, which means FY25's 6.6% top line is reporting yesterday's bookings strength, not tomorrow's.
**ROIC stepped down from 28.8% to 17.5% in FY25 and the M&A that caused it has not yet earned its capital.** The XponentL deal added ~$1.85B of goodwill/intangibles without commensurate operating income. If ATS margins do not scale by FY27, the market re-prices this as capital-mis-allocation — the exact signal Quant named as the question to monitor.
**The $6M off-cycle CEO retention RSU and the three-rebrand-in-24-months sequence both say "stressed."** Sherlock flagged the December 2025 retention grant to a 26-year lifer as proxy-flaggable. Historian flagged the tagline churn ("professional services firm" → "advanced technology services company" → "agentic and advanced technology solutions company") plus segment reclassifications that always let management point to the fastest-growing cut. Neither is fatal; together they say management is managing narrative harder than disclosure.
**Cheap is not the same as attractive — the market may be right about the multiple.** Warren: Genpact trades like CTSH (13.3x) not EXLS (20x) because the 76% Core book looks like commoditized offshore labor arbitrage on any honest read. If ATS stalls below 25% of revenue through FY26 and bookings decline again, the multiple is already fair at 10–11x, and there is no re-rating catalyst — just a 1.9% dividend and a 3% buyback running into a structurally-capped growth rate.
Close call, slight edge to the bulls at this price — but it is the price doing the work, not the fundamentals. At $36.65 with 11.6% FCF yield, a 10x forward P/E, Nalanda sitting patient, and Kalra having rebuilt guidance credibility, I'd lean cautiously long into the Q1'26 print, but with the understanding that this is a mispricing trade (close the peer gap to EXLS) rather than a secular compounder story. The item that tips the scale: Quant's chart of G at 1.44x EV/Sales vs EXLS at 2.43x with faster growth is not explainable by fundamentals alone — it is explainable by skepticism about ATS durability, and that skepticism has a testable expiration date in two weeks. What would flip me to the Against side: any Q1 print that shows ATS below 15% growth, or a second consecutive year of bookings decline disclosed on the call rather than buried in the K. That single data point makes Warren's giveback math the dominant read and resets the multiple lower — there is no version of this thesis where you own a 10x stock whose forward growth rate is actually 4%.